Phage treatment and wetland technology as intervention strategy to prevent dissemination of antibiotic resistance in surface waters

城市废水含有抗生素残留物和人类来源的微生物，包括众所周知的对抗生素具有耐药性的人类致病细菌（病原体）。这些可能经受得住废水处理厂的传统处理或人工湿地的被动处理，特别是在低收入至中等收入国家（LMIC），这对健康构成严重风险。在这项拟议的研究中，Phageland财团旨在开发一种新的低成本，安全，生态友好和可扩展的干预策略，以防止抗生素耐药性（AR）从废水传播到地表沃茨。这将通过结合使用特定的细菌感染病毒（噬菌体，也称为噬菌体）来实现，以创建一个基于噬菌体的处理与人工湿地作为被动水处理系统相结合。研究合作伙伴将评估这项技术在去除废水中主要抗生素耐药性病原体方面的功效，生态安全，包括保护天然细菌多样性，以及对包括动物在内的更广泛环境的潜在副作用。PhageLand技术还将在一个扩大的试点基础设施中进行测试，以证明该战略的概念及其在经济制约因素限制建设更昂贵和耗电量更大的处理技术的中低收入国家部署的可行性。该项目将结合实地和实验室实验，包括尖端技术和环境工程，以解决目前的知识差距，并评估和发展噬菌体土地技术。最初的重点将是后苏联的欧洲LMIC，特别是摩尔多瓦作为一个示范国家，这在历史上一直被忽视的LMIC作为一个整体。然而，拟议的技术将普遍适用，并很容易转让给其他国家，无论其经济地位如何。

Urban wastewater contains antibiotic residues and human-derived microorganisms, including well-known human disease causing bacteria (pathogens) which are resistant to antibiotics. These may withstand either traditional treatment in waster water treatment plants or passive treatment in constructed wetlands presenting a serious health risk particularly in Low to Middle Income Countries (LMIC). In this proposed research, the Phageland consortium aims to develop a new low-cost, safe, eco-friendly and scalable intervention strategy to prevent the transmission of antibiotic resistance (AR) from wastewater into surface waters. This will be achieved by combining the use of specific bacteria-infecting viruses (bacteriophages also known as phages) to created a phage-based treatment in combination with constructed wetlands acting as passive water treatment systems. The research partners will evaluate this technology with respect to its efficacy in removing key antibiotic resistant pathogens from wastewater, ecological safety, including preservation of natural bacterial diversity, and potential side effects for the wider environment including animals.The PhageLand technology will also be tested in a scaled-up pilot infrastructure as a proof-of-concept for the strategy and its viability for deployment in LMICs where economic constraints limit the construction of more costly and power hungry treatment technologies. The project will use a combination of field and laboratory experiments, including cutting edge techniques and environmental engineering, to address current gaps in knowledge and both assess and develop the PhageLand technology.The initial focus will be on post-Soviet European LMICs, and specifically Moldova as a model country, which have historically been overlooked amongst LMICs as a whole. However, the proposed technology will be universally applicable and easily transferred to other countries regardless of economic status.